Northern Trust’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Sell |
570,781
-13,407
| -2% | -$50K | ﹤0.01% | 2943 |
|
|
2025
Q1 | $1.61M | Sell |
584,188
-6,983
| -1% | -$19.3K | ﹤0.01% | 3034 |
|
|
2024
Q4 | $3.28M | Buy |
591,171
+127,296
| +27% | +$705K | ﹤0.01% | 2760 |
|
|
2024
Q3 | $3.87M | Buy |
463,875
+116,108
| +33% | +$968K | ﹤0.01% | 2627 |
|
|
2024
Q2 | $2.37M | Sell |
347,767
-8,029
| -2% | -$54.7K | ﹤0.01% | 2810 |
|
|
2024
Q1 | $2.33M | Sell |
355,796
-2,708
| -0.8% | -$17.8K | ﹤0.01% | 2879 |
|
|
2023
Q4 | $2.33M | Buy |
358,504
+10,184
| +3% | +$66.1K | ﹤0.01% | 2907 |
|
|
2023
Q3 | $1.75M | Sell |
348,320
-13,295
| -4% | -$66.9K | ﹤0.01% | 3014 |
|
|
2023
Q2 | $3.16M | Buy |
361,615
+306,536
| +557% | +$2.68M | ﹤0.01% | 2755 |
|
|
2023
Q1 | $652K | Buy |
55,079
+23,486
| +74% | +$278K | ﹤0.01% | 3354 |
|
|
2022
Q4 | $322K | Buy |
31,593
+10,089
| +47% | +$103K | ﹤0.01% | 3653 |
|
|
2022
Q3 | $127K | Buy |
21,504
+7,131
| +50% | +$42.1K | ﹤0.01% | 4033 |
|
|
2022
Q2 | $36K | Sell |
14,373
-90,449
| -86% | -$227K | ﹤0.01% | 4502 |
|
|
2022
Q1 | $311K | Sell |
104,822
-7,214
| -6% | -$21.4K | ﹤0.01% | 3933 |
|
|
2021
Q4 | $792K | Sell |
112,036
-4,880
| -4% | -$34.5K | ﹤0.01% | 3630 |
|
|
2021
Q3 | $1.22M | Buy |
116,916
+30,133
| +35% | +$314K | ﹤0.01% | 3489 |
|
|
2021
Q2 | $1.06M | Sell |
86,783
-5,004
| -5% | -$61.4K | ﹤0.01% | 3513 |
|
|
2021
Q1 | $2.02M | Buy |
+91,787
| New | +$2.02M | ﹤0.01% | 3236 |
|